DeliReP: Delirium Detection in Pediatric Intensive Care Unit Through a French Translation of the CAPD : a French Monocentric Observational Study

Sponsor
Assistance Publique - Hôpitaux de Paris (Other)
Overall Status
Withdrawn
CT.gov ID
NCT04954261
Collaborator
(none)
0
1

Study Details

Study Description

Brief Summary

The purpose of this study is to introduce delirium detection and try to determine the prevalence of delirium in Pediatric Intensive Care Unit (PICU) using a validated tool : the Cornell Assessment of Pediatric Delirium (CAPD) for every patient twice a day.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: CAPD

Detailed Description

Delirium is a frequent affection in ICU. In adult population, its prevalence is 20-50% in non intubated patients and 60-80% in patients under invasive ventilation. It is also frequent in paediatric population, but less diagnosed, whereas it can lead to higher duration stay, higher morbidity, traumatic injuries, acute stress, memory losses and post-traumatic stress syndrome. Since 2016, international guidelines recommend to look for delirium in paediatric population in PICU. There are 3 recommended tools to diagnose this affection: psCAM-ICU (6 months-5 years old), pCAM-ICU (5 years old-18 years old) and CAPD (birth-18 years old).

None of these validated tools have been translated in French.

The principal objective is to study the practicability of twice a day detection of delirium in PICU using the CAPD.

Investigators will first used a validation process to translate the CAPD in French, based on the validation method for psychological questionnaires suggested by Vallerand.

Then they will ask the paramedics to evaluate through the CAPD every consecutive patient/12 hours, every day during their stay in PICU, except for those completely unresponsive or under curare. This systematic evaluation will take place for 2 consecutive months.

For every patient, data will be collected about their age, sexe, term of birth, mental affection status, diagnosis at entry, and daily risk of mortality score, length of stay, ventilation, pain evaluation and treatment, withdrawal evaluation, surroundings, use of hypnotic treatment, steroids, opioids and ketamine.

The secondary aims are to determine the prevalence of delirium with the data collected, to ask whether or not the French version of CAPD has been easily and correctly used, can help to diagnose delirium, and whether investigators can find some associated parameters to delirium.

Study Design

Study Type:
Observational
Actual Enrollment :
0 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Implementing Delirium Detection in Pediatric Intensive Care Unit Through a French Translation of the CAPD : a French Monocentric Observational Study
Actual Study Start Date :
Dec 6, 2018
Actual Primary Completion Date :
Dec 6, 2018
Actual Study Completion Date :
Dec 6, 2018

Outcome Measures

Primary Outcome Measures

  1. Prevalence of delirium in the PICU population [2 months]

    Number of CAPD evaluated > 9 / total number of CAPD evaluated

Secondary Outcome Measures

  1. Applicability of the CAPD by the paramedics [Before inclusion period]

    5 questions : Whether or not they have already heard about delirium Whether or not they know the symptoms of delirium in children and adolescents Whether or not they have already been confronted to a state of delirium in the Pediatric Intensive Care Unit Whether of not they think it would be useful to have a specific scale to diagnose delirium in the Pediatric Intensive Care Unit Whether or not they think it would be feasible to use such a scale regularly in the Pediatric Intensive Care Unit The proposed answers will be Yes, No or I don't know for each question The analysis will be qualitative and quantitative.

  2. Applicability of the CAPD by the paramedics after the 2 months period [2 months]

    The same 5 questions of the pre-test, 5 new closed-ended questions and 3 open-ended questions : Whether or not they had difficulties evaluating patients with the CAPD How they evaluate the duration of the evaluation by the CAPD Whether or not they evaluated the patients with a colleague Whether or not they think that the assessment of delirium by the CAPD is relevant among PICU patients Whether or not they think that a long-term evaluation of delirium by the CAPD is feasible in this PICU unit 1- If difficulties of evaluating patients with the CAPD : quote the difficulties 2- In which categories of patients do they think that the CAPD in not adapted 3- Comment or suggestions to improve the use of the scale

  3. Use of the CAPD by the paramedics [2 months]

    % of CAPD completed during the 2 months period

  4. Age [2 months]

    Potential associated factors to delirium

  5. Sex [2 months]

    Potential associated factors to delirium

  6. Term of birth [2 months]

    Potential associated factors to delirium

  7. Prior neurological impairment [2 months]

    Potential associated factors to delirium

  8. Diagnosis (motivating hospitalization in intensive care) [2 months]

    Potential associated factors to delirium

  9. Severity score on arrival (PIM 3) [2 months]

    Potential associated factors to delirium. Pediatric Index of Mortality (PIM) 3 is a published and open acces program whith 10 variables about the patients (7 binary variables and 3 quantitative ones), that predicts the death probability of the patient. One evaluation per patient at the admission in the PICU unit.

  10. Daily severity score (PELOD 2) [2 months]

    Potential associated factors to delirium. PELOD 2 (PEdiatric Logistic Organ Dysfunction) is a published and open acces program that includes ten variables corresponding to five organ dysfunctions. It predicts a daily percentage of mortality. One evaluation per day per patient during the PICU unit stay.

  11. Duration of hospitalization [2 months]

    Potential associated factors to delirium

  12. Death or survival of the patient [2 months]

    Potential associated factors to delirium

  13. Mechanical ventilation, non invasive ventilation or spontaneous ventilation [2 months]

    Potential associated factors to delirium

  14. Mechanical ventilation time [2 months]

    Potential associated factors to delirium

  15. Presence of parents [2 months]

    Potential associated factors to delirium

  16. Presence of pain [2 months]

    Potential associated factors to delirium. Pain was evaluated through the appropriate scale amongst : Comfort B (pediatric behavioural scale, ventilated, sedated and/or comatose patient): seven items scored 1 to 5, a total score greater than or equal to 17/35 indicating a state of pain, or EVENDOL (behavioural scale for conscious patients between birth and 6 years old): five items scored 0 to 3, a total score greater than or equal to 3/15 indicating a state of pain, or FLACC (Face Leg Activity Cry Consolability) (pediatric behavioural scale, usable in patients with cognitive impairment): five items scored 0 to 2, a total score greater than or equal to 3/10 indicating a state of pain, Patients able to assess pain felt : Numerical Scale (for patients over 10 years old) a score greater than or equal to 3/10 indicating a state of pain, or Visual Analogue Scale (for patients between 6 and 10 years old), a score greater than or equal to 3/10 indicating a state of pain.

  17. withdrawal or not [2 months]

    Potential associated factors to delirium. Withdrawal was evaluated through the scale WAT-1 (Wthdrawal Assessing tool version 1): ten items scored 0 or 1, and 1 item scored 0 to 2, a total score greater than or equal to 3/12 indicating a state of withdrawal.

  18. Use of benzodiazepines, ketamine, corticosteroids or opioids [2 months]

    Potential associated factors to delirium

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Being hospitalized in PICU during the inclusion period

  • Age 0 to 18 years old

Exclusion Criteria:
  • Patient with a state of sedation that does not allow the assessment of a change in the state of consciousness or cognitive functioning (equivalent score Richmond Agitation-Sedation Scale RASS <-3 or COMFORT B <11)

  • Patient or Parental opposition to the observational study

Contacts and Locations

Locations

Site City State Country Postal Code
1 Necker Enfants Malades Hospital Paris France 75015

Sponsors and Collaborators

  • Assistance Publique - Hôpitaux de Paris

Investigators

  • Principal Investigator: Laure De Saint Blanquat, MD, PhD, Assistance Publique - Hôpitaux de Paris

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier:
NCT04954261
Other Study ID Numbers:
  • NI18018J
  • 2018-A00763-52
First Posted:
Jul 8, 2021
Last Update Posted:
Dec 10, 2021
Last Verified:
Dec 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Assistance Publique - Hôpitaux de Paris
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 10, 2021